SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (20451)4/14/1999 8:02:00 PM
From: AlienTech  Respond to of 23519
 
>>Frostman...looking for Vivus to expand their work on Gene Therapy beyond the ED market.
Can this work improve blood flow to other body parts...improve circulation of blood in Diabetic and others....????????<<

I think Leyland should be the first subject of this test. Lets see if his mind improves after the therapy.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News